Stehman-Breen Catherine bought DYN
June 5, 2026 · Form 4 insider transaction
Stehman-Breen Catherine bought 35,152 shares of Dyne Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
35,152
Price
$0.00
Total value
N/A
InsiderStehman-Breen Catherine
RoleDirector
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 5, 2026
Filing dateJune 9, 2026
Shares owned after35,152
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on June 5, 2026. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 5, 2027 or (ii) the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to continued service.